Cargando…

Title: Severe Extra Pyramidal symptoms vs Neuroleptic Malignant Syndrome following long acting depot formulation of typical antipsychotic- a diagnostic dilemma and its management: a case report.

BACKGROUND: Flupenthixol Decanoate is a long acting typical antipsychotic which mainly acts as an antagonist of central D2 receptors but the chances of both EPS and NMS are high with its use.In this case report we are going to discuss how challenging it might be sometimes to differentiate between se...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129775/
http://dx.doi.org/10.4103/0019-5545.341946
_version_ 1784712838185484288
collection PubMed
description BACKGROUND: Flupenthixol Decanoate is a long acting typical antipsychotic which mainly acts as an antagonist of central D2 receptors but the chances of both EPS and NMS are high with its use.In this case report we are going to discuss how challenging it might be sometimes to differentiate between severe EPS and NMS due to some of its overlapping symptoms and dramatic presentation and how to manage promptly to prevent ICU admission and subsequent mortality. CASE: Here, we are reporting this unique case of a 19 years old boy belonging from lower middle Socio- economic status, residing in urban area, who developed severe EPS like tremors, severe rigidity, sialorrhea, dystonia, occulogyric crisis, akathisia following administration of long acting injection of Flupenthixol deacanoate at a high dose and was on the verge of progression to full blown NMS, and how it improved by timely intervention with appropriate combination of Dopamine agonists, anticholinergics and conservative management. CONCLUSION: Our study explains that by prompt recognition of symptoms and timely intervention by appropriate agents, progression of severe EPS to NMS can be prevented and hence the mortality can be reduced and quality of life can be improved.Our study also emphasizes on certain aspects which has to be kept in mind by mental health professionals during use of typical LAIs to prevent serious consequences.
format Online
Article
Text
id pubmed-9129775
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-91297752022-05-25 Title: Severe Extra Pyramidal symptoms vs Neuroleptic Malignant Syndrome following long acting depot formulation of typical antipsychotic- a diagnostic dilemma and its management: a case report. Indian J Psychiatry Abstract- Poster BACKGROUND: Flupenthixol Decanoate is a long acting typical antipsychotic which mainly acts as an antagonist of central D2 receptors but the chances of both EPS and NMS are high with its use.In this case report we are going to discuss how challenging it might be sometimes to differentiate between severe EPS and NMS due to some of its overlapping symptoms and dramatic presentation and how to manage promptly to prevent ICU admission and subsequent mortality. CASE: Here, we are reporting this unique case of a 19 years old boy belonging from lower middle Socio- economic status, residing in urban area, who developed severe EPS like tremors, severe rigidity, sialorrhea, dystonia, occulogyric crisis, akathisia following administration of long acting injection of Flupenthixol deacanoate at a high dose and was on the verge of progression to full blown NMS, and how it improved by timely intervention with appropriate combination of Dopamine agonists, anticholinergics and conservative management. CONCLUSION: Our study explains that by prompt recognition of symptoms and timely intervention by appropriate agents, progression of severe EPS to NMS can be prevented and hence the mortality can be reduced and quality of life can be improved.Our study also emphasizes on certain aspects which has to be kept in mind by mental health professionals during use of typical LAIs to prevent serious consequences. Wolters Kluwer - Medknow 2022-03 2022-03-24 /pmc/articles/PMC9129775/ http://dx.doi.org/10.4103/0019-5545.341946 Text en Copyright: © 2022 Indian Journal of Psychiatry https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Abstract- Poster
Title: Severe Extra Pyramidal symptoms vs Neuroleptic Malignant Syndrome following long acting depot formulation of typical antipsychotic- a diagnostic dilemma and its management: a case report.
title Title: Severe Extra Pyramidal symptoms vs Neuroleptic Malignant Syndrome following long acting depot formulation of typical antipsychotic- a diagnostic dilemma and its management: a case report.
title_full Title: Severe Extra Pyramidal symptoms vs Neuroleptic Malignant Syndrome following long acting depot formulation of typical antipsychotic- a diagnostic dilemma and its management: a case report.
title_fullStr Title: Severe Extra Pyramidal symptoms vs Neuroleptic Malignant Syndrome following long acting depot formulation of typical antipsychotic- a diagnostic dilemma and its management: a case report.
title_full_unstemmed Title: Severe Extra Pyramidal symptoms vs Neuroleptic Malignant Syndrome following long acting depot formulation of typical antipsychotic- a diagnostic dilemma and its management: a case report.
title_short Title: Severe Extra Pyramidal symptoms vs Neuroleptic Malignant Syndrome following long acting depot formulation of typical antipsychotic- a diagnostic dilemma and its management: a case report.
title_sort title: severe extra pyramidal symptoms vs neuroleptic malignant syndrome following long acting depot formulation of typical antipsychotic- a diagnostic dilemma and its management: a case report.
topic Abstract- Poster
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129775/
http://dx.doi.org/10.4103/0019-5545.341946